Literature DB >> 3770048

Survival after first recurrence in breast cancer.

P Hietanen, M Miettinen, J Mäkinen.   

Abstract

The aim of the present study was to evaluate the significance of primary stage, histopathological grade, disease-free survival and site of first relapse on survival after first recurrence. The study included 1621 female breast cancer patients admitted between 1970 and 1975. The patient material was analysed by unifactorial life table methods and the multifactorial Cox regression analysis. The primary stage and histopathological grade maintained a significant prognostic value also after relapse. Survival after first recurrence was dependent on the disease-free interval and site of first relapse, too. If the disease-free survival was over 5 years, 44% of the patients were still alive after 7 years from recurrence. Of the patients with a disease-free survival shorter than 2 years, only 10% were alive after 7 years from recurrence. Survival was significantly better after locoregional relapse than after distant relapse, but the difference levelled off within 7 years. The prognosis of axillary relapse was best and that of liver and brain metastases poorest. Regression analysis confirmed the importance of primary stage, site of recurrence and histopathological grade as prognostic variables for survival after first recurrence.

Entities:  

Mesh:

Year:  1986        PMID: 3770048     DOI: 10.1016/0277-5379(86)90056-8

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  10 in total

1.  Retrospective analysis for evaluation of the value of contrast-enhanced MRI in patients treated with breast conservative therapy.

Authors:  P Viehweg; A Heinig; D Lampe; J Buchmann; S H Heywang-Köbrunner
Journal:  MAGMA       Date:  1998-12       Impact factor: 2.310

2.  Influence of S-phase fraction on metastatic pattern and post-recurrence survival in a randomized mammography screening trial.

Authors:  T Hatschek; J Carstensen; G Fagerberg; O Stål; O Gröntoft; B Nordenskjöld
Journal:  Breast Cancer Res Treat       Date:  1989-12       Impact factor: 4.872

Review 3.  The significance of a supraclavicular node metastasis in patients with breast cancer. A literature review.

Authors:  J M Debois
Journal:  Strahlenther Onkol       Date:  1997-01       Impact factor: 3.621

4.  Plasma TGF-beta1-related survival of postmenopausal metastatic breast cancer patients.

Authors:  D Nikolić-Vukosavljević; N Todorović-Raković; M Demajo; V Ivanović; B Nesković; M Markićević; Z Nesković-Konstantinović
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

5.  Possible adverse effect of failed adjuvant chemotherapy on the prognosis of women receiving consecutive chemotherapy for recurrent breast cancer.

Authors:  C Dittrich; R Jakesz; K Pirich; L Havelec; G Steger; O Schlappack; R Kolb; K Moser
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

6.  Survival effect of systemic therapy on patients developing metastatic breast carcinoma.

Authors:  J Rouesse; S Friedman; I Guash-Jordan; K Hacene; M Brunet
Journal:  Breast Cancer Res Treat       Date:  1990-01       Impact factor: 4.872

7.  Brain metastases in breast cancer; natural history, prognostic factors and outcome.

Authors:  W Boogerd; V W Vos; A A Hart; G Baris
Journal:  J Neurooncol       Date:  1993-02       Impact factor: 4.130

8.  Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading.

Authors:  G Blanco; K Holli; M Heikkinen; O P Kallioniemi; P Taskinen
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

9.  Reirradiation combined with hyperthermia in recurrent breast cancer results in a worthwhile local palliation.

Authors:  J van der Zee; B van der Holt; P J Rietveld; P A Helle; A J Wijnmaalen; W L van Putten; G C van Rhoon
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

10.  Histological grade and steroid receptor content of primary breast cancer--impact on prognosis and possible modes of action.

Authors:  C Kamby; J Andersen; B Ejlertsen; N E Birkler; L Rytter; K Zedeler; S M Thorpe; T Nørgaard; C Rose
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.